Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: Results from a single-institution hospital-based observational cohort study
P. Quaglino, F. Marenco, S. Osella-Abate, N. Cappello, M. Ortoncelli, B. Salomone, M. T. Fierro, P. Savoia, M. G. Bernengo
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: Results from a single-institution hospital-based observational cohort study'. Together they form a unique fingerprint.